| 1 |
35115900 | Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET. | 2022 |
3 |
| 2 |
35176901 | Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. | 2022 Jan-Dec |
2 |
| 3 |
33489855 | Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells. | 2021 Jan |
2 |
| 4 |
32208383 | Aberrant cell migration contributes to defective airway epithelial repair in childhood wheeze. | 2020 Apr 9 |
1 |
| 5 |
32705218 | Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway. | 2020 Sep |
1 |
| 6 |
33019464 | The molecular mechanisms of celecoxib in tumor development. | 2020 Oct 2 |
1 |
| 7 |
31613929 | Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression. | 2019 |
3 |
| 8 |
29541415 | Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death. | 2018 Feb 16 |
1 |
| 9 |
29593389 | Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells. | 2018 |
1 |
| 10 |
30326204 | The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. | 2018 Dec |
1 |
| 11 |
27666139 | Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production. | 2017 Apr |
1 |
| 12 |
28053596 | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. | 2017 |
3 |
| 13 |
28283800 | Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma. | 2017 Apr |
2 |
| 14 |
28804691 | Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas. | 2017 |
1 |
| 15 |
29048666 | Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN. | 2017 Nov |
3 |
| 16 |
29216640 | Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. | 2017 |
3 |
| 17 |
26899878 | Comparative Proteomic Study of Fatty Acid-treated Myoblasts Reveals Role of Cox-2 in Palmitate-induced Insulin Resistance. | 2016 Feb 22 |
1 |
| 18 |
27835884 | Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. | 2016 Dec 20 |
1 |
| 19 |
25701378 | Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. | 2015 Jul |
5 |
| 20 |
25770423 | Activating PTEN by COX-2 inhibitors antagonizes radiation-induced AKT activation contributing to radiosensitization. | 2015 May 1 |
2 |
| 21 |
25851346 | Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. | 2015 Aug |
2 |
| 22 |
25964548 | Combining CAL-101 with Celecoxib Enhances Apoptosis of EBV-transformed B-Cells Through MAPK-induced ER Stress. | 2015 May |
1 |
| 23 |
26225471 | The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment. | 2015 Oct |
2 |
| 24 |
24520227 | Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. | 2014 Jan |
1 |
| 25 |
24676394 | Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells. | 2014 Jun |
4 |
| 26 |
24855827 | Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines. | 2014 May |
2 |
| 27 |
25107843 | The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor. | 2014 Jul |
1 |
| 28 |
23229294 | Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. | 2013 Feb |
1 |
| 29 |
23524145 | Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib. | 2013 Jun 10 |
1 |
| 30 |
23564777 | Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro. | 2013 Apr |
1 |
| 31 |
23679684 | Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. | 2013 Nov |
2 |
| 32 |
23833672 | Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer. | 2013 Jun |
2 |
| 33 |
22546756 | Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway. | 2012 Jul |
1 |
| 34 |
21430081 | Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model. | 2011 Jul |
1 |
| 35 |
21807123 | The acid sphingomyelinase inhibitors block interferon-α-induced serotonin uptake via a COX-2/Akt/ERK/STAT-dependent pathway in T cells. | 2011 Nov |
1 |
| 36 |
21868755 | Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. | 2011 Oct 1 |
3 |
| 37 |
19954924 | Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. | 2010 May |
2 |
| 38 |
20083195 | Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. | 2010 Apr 15 |
3 |
| 39 |
20578837 | Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. | 2010 Jun |
1 |
| 40 |
20664740 | Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers. | 2010 Jul |
1 |
| 41 |
20926014 | Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice. | 2010 Jul-Aug |
2 |
| 42 |
18506760 | Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. | 2009 Jan |
1 |
| 43 |
18823436 | Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. | 2009 Mar |
2 |
| 44 |
19558494 | Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways. | 2009 Nov |
1 |
| 45 |
19787257 | Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. | 2009 Nov |
1 |
| 46 |
21556247 | Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro. | 2009 Apr 7 |
2 |
| 47 |
18078766 | Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. | 2008 May |
3 |
| 48 |
18083230 | Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. | 2008 Jun |
2 |
| 49 |
18172786 | Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. | 2008 |
1 |
| 50 |
18201156 | Celecoxib to prevent restenosis--results from the COREA-TAXUS trial. | 2008 Feb |
2 |